People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Computers, Software / Tech, Healthtech, Biotechnology, Other Technology, Manufacturing / Industrial
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Panzura, Inc. | — | Computers | Series B | $70.4M | $809.9M | 2010 |
| Post Acute Analytics, Inc. | — | Software / Tech | Series C | $49.9M | $809.8M | 2019 |
| ClinicaHealth, Inc. | — | Healthtech | Series B | $37.3M | $313.2M | 2014 |
| Spyryx Biosciences, Inc. | — | Biotechnology | Series B | $29.1M | $235.4M | 2015 |
| Vendini, Inc. | — | Other Technology | Series B | $20.0M | $609.1M | 2016 |
| e-cast Inc | — | Other Technology | Series B | $18.0M | $30.5M | 2009 |
| GPMS International, Inc. | — | Other Technology | Series A | $14.9M | $7.6M | 2021 |
| RICS Software, Inc. | — | Other Technology | Series A | $4.1M | $114.4M | 2012 |
| Luxor Industrial Corp /Fi | — | Manufacturing / Industrial | Pre-Seed | $174K | $2.6M | 2016 |
| Gracili Therapeutics, Inc. | — | Pharmaceuticals | Pre-Seed | $100K | $4.7M | 2020 |
John Taylor at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside John Taylor on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Rogers | 1 | 20 |
| Paul Madera | 1 | 11 |
| Mark Brown | 1 | 10 |
| Shirish Sathaye | 1 | 9 |
| Tim Shannon | 1 | 9 |
| Daniel Levine | 1 | 8 |
| David Becker | 1 | 7 |
| Andrew Verhalen | 1 | 6 |
| Gill Cogan | 1 | 6 |
| Christy Shaffer | 1 | 6 |
| Michael Morgan | 1 | 6 |
| Barry Goldsmith | 1 | 6 |
| James Feuille | 1 | 5 |
| Carl Showalter | 1 | 5 |
| Brian Daniels | 1 | 5 |
| George McCulloch | 1 | 5 |
| Arnold Whitman | 1 | 4 |
| James MacIntyre | 1 | 4 |
| Brian Flynn | 1 | 4 |
| John F Taylor | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.